p21 gene therapy
Latest Information Update: 30 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Gene therapies
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bladder cancer; Non-small cell lung cancer; Vascular restenosis
Most Recent Events
- 13 Jul 1999 Preclinical development for Bladder cancer in South Korea (Intraperitoneal)
- 19 Jun 1998 Preclinical development for Non-small cell lung cancer in USA (Intratumoural)
- 11 Dec 1997 New profile